tiprankstipranks
Trending News
More News >
Balaxi Pharmaceuticals Limited (IN:BALAXI)
:BALAXI
India Market

Balaxi Pharmaceuticals Limited (BALAXI) Income Statement

Compare
0 Followers

Balaxi Pharmaceuticals Limited Income Statement

Last quarter (Q3 2025), Balaxi Pharmaceuticals Limited's total revenue was ₹732.91M, an increase of 20.57% from the same quarter last year. In Q3, Balaxi Pharmaceuticals Limited's net income was ₹53.63M. See Balaxi Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 2.89B₹ 2.41B₹ 3.36B₹ 2.79B₹ 2.31B
Gross Profit
₹ 1.18B₹ 1.13B₹ 1.34B₹ 837.91M₹ 591.85M
Operating Expenses
₹ 0.00₹ 656.74M₹ 792.32M₹ 334.80M₹ 167.68M
Depreciation and Amortization
₹ 18.95M₹ 20.98M₹ 2.80B₹ 2.29B₹ 1.89B
EBITDA
₹ 305.64M₹ 456.59M₹ 591.75M₹ 551.76M₹ 446.83M
Operating Income
₹ 286.70M₹ 467.31M₹ 574.22M₹ 546.64M₹ 443.85M
Other Income/Expenses
₹ 0.00₹ -447.15M₹ 3.85M₹ -1.42M₹ -555.00K
Pretax Income
₹ 286.70M₹ 20.15M₹ 569.22M₹ 545.22M₹ 443.29M
Net Income
₹ 250.70M₹ -23.87M₹ 459.63M₹ 476.58M₹ 381.37M
Per Share Metrics
Basic EPS
₹ 4.54₹ -0.46₹ 9.16₹ 9.53₹ 7.63
Diluted EPS
₹ 4.54₹ -0.46₹ 9.08₹ 9.53₹ 7.63
Weighted Average Shares Outstanding
0.00 52.67M 52.67M 52.67M 52.67M
Weighted Average Shares Outstanding (Diluted)
0.00 52.67M 52.67M 52.67M 52.67M
Currency in INR

Balaxi Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis